European Archives - Page 802 of 1303 - European Medical Journal

This site is intended for healthcare professionals

Continue
EMJ Oncology 8.1 2020 Feature Image
1 Mins
5 Nov 2020

Identifying the Best Ki67 Cut-Off for Determining Luminal Breast Cancer Subtypes Using Immunohistochemical Analysis and PAM50 Genomic Classification

Gene expression profiling has a significant impact on understanding the biology of breast cancer (BC)…
11 Mins
5 Nov 2020

Oncogenic Drivers in Advanced NSCLC: Navigating an Evolving Landscape to Optimise Patient Outcomes

The oncology community has been experiencing an unprecedented moment in lung cancer diagnosis and treatment; however, despite significant…
EMJ Oncology 8.1 2020 Feature Image
1 Mins
5 Nov 2020

Prognostic Value of Compartmental Spatial Analysis of Tumour-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

Analyses on tumour-infiltrating lymphocytes (TIL) to date have mainly evaluated stromal TIL and possibly intratumoural TIL…
Congress Interview Professor John B.A.G. Haanen
3 Mins
5 Nov 2020

ESMO Congress Interview: Professor John B.A.G. Haanen

You have an impressive scientific background, completing a scientific PhD in immunohaematology in addition to your clinical training…
EMJ Oncology 8.1 2020 Feature Image
1 Mins
5 Nov 2020

Long-term Survival Following Photodynamic Therapy for Glioma Depending on MGMT

The gross total resection of a glial tumour is the aim of complex treatment and gives greater efficiency of the subsequent treatment stages, defining patients’ longevity…
Interview: Dr Vinay Prasad
6 Mins
5 Nov 2020

Interview: Dr Vinay Prasad

You have an impressive background in science communication within the medical field, not only working with patients as a haematologist…
EMJ Oncology 8.1 2020 Feature Image
1 Mins
5 Nov 2020

Long-Term Follow-Up of Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Report From the Spanish Lymphoma Oncology Group

Nodular lymphocytic predominance Hodgkin lymphoma (NLPHL) is a very uncommon subtype of Hodgkin lymphoma (HL), representing approximately 5% of all HL cases, with an incidence of 0.3/100,000 cases per year and with unique characteristics that distinguish it from classic HL…
EMJ Oncology 8.1 2020 Feature Image
2 Mins
5 Nov 2020

Evolution of Adjuvant Therapy in Radically Resected Carcinoma Gallbladder Over a Decade: A Real-World Experience from a Regional Cancer Centre

Because of the rarity and high mortality of gallbladder cancer (GBC), the best adjuvant modality of radically resected GBC is not well established…
EMJ Oncology 8.1 2020 Feature Image
2 Mins
5 Nov 2020

Safety of Fertility Treatments in Breast Cancer Survivors

Quality of life for cancer survivors has become a priority in cancer care and research. Almost 50% of the young patients who have survived breast cancer (BC) have expressed their desire to become pregnant…
EMJ Oncology 8.1 2020 Feature Image
11 Mins
5 Nov 2020

The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma

Cholangiocarcinomas (CCA) belong to the constellation of biliary tract cancers (BTC), along with gallbladder carcinomas and ampullary carcinomas…
We’ve noticed you’re accessing
from North/South America.